Press Releases

02/08/17
BioRestorative Therapies Receives FDA Clearance to Initiate Phase 2 Clinical Trial for the Treatment of Patients with Degenerative Disc Disease
01/09/17
BioRestorative Therapies Submits IND Application to FDA to Treat Patients with Degenerative Disc Disease
09/12/16
BioRestorative Therapies Announces Publication in Medical Journal of Positive Results of Long-Term Safety and Feasibility Study Using Cell Therapy to Treat Patients with Degenerative Disc Disease
07/13/16
BioRestorative Therapies Announces Presentation at 3rd Annual Regenerative Medicine Essentials Course
06/28/16
BioRestorative Therapies Announces Completion of Human Safety and Feasibility Study on the Use of Hypoxic Cultured Stem Cells to Treat Chronic Lower Back Pain
05/31/16
BioRestorative Therapies to Present at 5th Annual Marcum MicroCap Conference
05/23/16
BioRestorative Therapies Announces Promising Data to Advance its Program for the Treatment of Metabolic Disorders
02/23/16
BioRestorative Therapies Deepens Board of Directors with Addition of Robert B. Catell, Former Chairman and CEO of KeySpan Corporation and Chairman of National Grid, US
02/09/16
BioRestorative Therapies Names Lead Cell-Based Lumbar Disc Therapeutic Product
12/21/15
BioRestorative Therapies Provides Company Updates with Shareholder Letter
12/02/15
BioRestorative Therapies Appoints John M. Desmarais, J.D. to its Board of Directors
11/19/15
BioRestorative Therapies Granted Key Metabolic Patent
11/03/15
BioRestorative Therapies Announces Patent Granted For Its Licensed Curved Needle Device
09/15/15
BioRestorative Therapies Announces Research Collaboration With University of Pennsylvania
07/20/15
BioRestorative Therapies to Evaluate Cell Delivery Technology to Advance Metabolic Program Towards Human Trials
07/06/15
BioRestorative Therapies, Inc. Announces Reverse Stock Split in Preparation for Planned Uplisting to NASDAQ Capital Market
06/02/15
BioRestorative Therapies Announces Conversion of $5.15 million of Debt to Equity
05/27/15
BioRestorative Therapies to Present ThermoStem® Data at 21st Annual Meeting of the International Society for Cellular Therapy
05/26/15
BioRestorative Therapies to Present at the 2015 Marcum MicroCap Conference in New York City
04/14/15
BioRestorative Therapies, Inc. Announces Opening of New Headquarters and Laboratory Facility in New York
04/08/15
BioRestorative Therapies Appoints Charles S. Ryan, J.D., Ph.D. to its Board of Directors
02/17/15
BioRestorative Therapies Announces the Appointment of Edward Field as President of the brtxDISC™ Division
02/05/15
BioRestorative Therapies, Inc. to Present at Inaugural Innovations Conference
02/02/15
BioRestorative Therapies Appoints Dr. Joy Cavagnaro to Scientific Advisory Board
01/12/15
BioRestorative Therapies Reports Successful Meeting with FDA
11/24/14
BioRestorative Therapies Schedules Pre-IND Meeting with FDA
10/09/14
BioRestorative Therapies Engages Access BIO to Support Advancement of brtxDISC™ Program into Clinical Studies
09/03/14
BioRestorative Therapies Announces Relocation To New York State
08/18/14
BioRestorative Therapies Engages Consulting Firm to Develop Strategic Partnerships in Japan and China
07/14/14
BioRestorative Therapies Issues Letter to Stockholders
07/02/14
BioRestorative Therapies Appoints Joseph B. Swiader to its Board of Directors
06/30/14
BioRestorative Therapies Appoints The Honorable Paul Jude Tonna to its Board of Directors
06/02/14
BioRestorative Therapies to Present at the Third Annual Marcum MicroCap Conference
05/22/14
BioRestorative Therapies Signs Research Agreement with Pfizer Inc.
04/14/14
BioRestorative Therapies Appoints Wayne Olan, M.D. to Scientific Advisory Board
03/25/14
BioRestorative Therapies Signs Research and Development Agreement with Rohto Pharmaceutical
03/04/14
BioRestorative Therapies Names Gregory Lutz, M.D. as Chief Medical Advisor for Spine Medicine
01/29/14
BioRestorative Therapies’ Brown Fat Stem Cells Research Published in February Issue of Stem Cells Journal
12/02/13
BioRestorative Therapies' ThermoStem® Brown Fat Stem Cell Study to be Published in Stem Cells
11/25/13
BioRestorative Therapies to Present at LD Micro Conference
11/20/13
BioRestorative Therapies to Present Preclinical Data from its ThermoStem® Brown Fat Stem Cell Program at Annual Meeting of the International Federation for Adipose Therapeutics and Science
09/30/13
BioRestorative Engages Consulting Firm to Advance brtxDISCTM Program Delivery Device through FDA Clearance Process
08/07/13
BioRestorative Therapies Receives Approval to Conduct Retrospective Safety Study on its Bulging/Herniated Disc Procedure
08/01/13
BioRestorative Therapies Provides Company Updates with Shareholder Letter
07/29/13
BioRestorative Therapies CEO Mark Weinreb Interviewed by The Life Sciences Report
06/24/13
BioRestorative Therapies Expands its ThermoStem® Program to 150 Stem Cell Lines
06/17/13
BioRestorative Therapies CEO Mark Weinreb Interviewed on “Next Big Thing” with Financial Personality and Founder Tobin Smith
05/29/13
BioRestorative Therapies Announces the Development of an Extract that has Promise for Use in Beauty Care Products
05/21/13
BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference
05/20/13
BioRestorative Therapies Signs Agreement with Dexterity, Inc. to Advance Production of the Company’s Novel brtxDISC™ Stem Cell Therapy Device
04/23/13
BioRestorative Therapies Appoints ProActive Capital Group as Capital Markets & Digital Media Advisor
04/15/13
BioRestorative Therapies Invited to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria
04/12/13
BioRestorative Therapies Announces One-for-Fifty Reverse Stock Split
04/09/13
BioRestorative Therapies Announces Chairman of Its Scientific Advisory Board to Speak at Vatican
01/14/13
BioRestorative Therapies Announces Participation in Adipose Tissue Biology Keystone Conference Series
11/26/12
BioRestorative Therapies Announces Launch of New Website
11/05/12
BioRestorative Therapies Announces Stock Trading On OTC Bulletin Board
09/25/12
BioRestorative Therapies Announces the Appointment of Harvard Medical School’s Wayne Marasco, M.D., Ph.D., as Chairman of its Scientific Advisory Board
09/19/12
BIORESTORATIVE THERAPIES, INC. BEGINS TRADING UNDER NEW NAME AND SYMBOL (“BRTX”)
07/16/12
BioRestorative Therapies, Inc. Announces Launch of New Stem Pearls® Website and E-Commerce Platform for Skincare Product Line
06/12/12
BioRestorative Therapies Enters Into Brown Fat Research Agreement With University of Utah
05/03/12
BioRestorative Therapies Announces Next Generation of Stem Cell Disc Delivery Device
04/11/12
BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure
04/10/12
BioRestorative Therapies Obtains $2.1 Million In 2012 Private Financing
04/03/12
BioRestorative Therapies Retains KCSA Strategic Communications as Investor Relations Counsel
01/31/12
BIORESTORATIVE THERAPIES SIGNS LICENSE AGREEMENT FOR STEM CELL DISC/SPINE PROCEDURE
01/23/12
BIORESTORATIVE THERAPIES TO PRESENT AT 7th INTERNATIONAL CONFERENCE ON CELL THERAPY FOR CARDIOVASCULAR DISEASE
12/08/11
BIORESTORATIVE THERAPIES SIGNS MATERIAL MANUFACTURING AGREEMENT WITH UNIVERSITY OF UTAH
08/25/11
BIORESTORATIVE THERAPIES SIGNS LICENSE AGREEMENT WITH UNIVERSITY OF UTAH TO OBTAIN ADIPOSE (FAT) TISSUE FOR ITS THERMOSTEM PROGRAM TO TREAT OBESITY AND METABOLIC DISORDERS
08/22/11
BIORESTORATIVE THERAPIES, INC. ANNOUNCES UPGRADE TO OTCQB MARKET
07/06/11
STEM CELL ASSURANCE ANNOUNCES THE APPOINTMENT OF AMIT N. PATEL, M.D., M.S., TO ITS SCIENTIFIC ADVISORY BOARD
06/30/11
STEM CELL ASSURANCE ANNOUNCES THE LAUNCH OF ITS BROWN FAT STEM CELL THERAPEUTIC AND COSMETIC PLATFORM TECHNOLOGY PROGRAM
06/20/11
STEM CELL ASSURANCE ANNOUNCES THE APPOINTMENT OF NAIYER IMAM, M.D., M.SC., TO ITS NEWLY ESTABISHED SCIENTIFIC ADVISORY BOARD
04/12/11
Stem Cell Assurance Announces Hiring Of Vice President Of Research And Development
BioRestorative Therapies: A Stem Cell Biotechnology Company